{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:49:21Z","timestamp":1793450961203,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Chem"],"DOI":"10.1038\/s42004-025-01744-3","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:07:43Z","timestamp":1763471263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Hybrid compound H93 treats prostate cancer by directly binding UHRF1 and promoting protein dimerization"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8626-9040","authenticated-orcid":false,"given":"Yuxin","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-9878","authenticated-orcid":false,"given":"Longying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8139-6892","authenticated-orcid":false,"given":"Yongheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-4401","authenticated-orcid":false,"given":"Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1744_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.eururo.2019.09.004","volume":"77","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen, N. J. et al. Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis. Eur. Urol. 77, 365\u2013372 (2020).","journal-title":"Eur. Urol."},{"key":"1744_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/iju.13512","volume":"25","author":"K Komura","year":"2018","unstructured":"Komura, K. et al. Current treatment strategies for advanced prostate cancer. Int. J. Urol. 25, 220\u2013231 (2018).","journal-title":"Int. J. Urol."},{"key":"1744_CR3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"JS de Bono","year":"2011","unstructured":"de Bono, J. S. et al. Abiraterone and increased survival in metastatic prostate cancer. N. Engl. J. Med. 364, 1995\u20132005 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1744_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher, H. I. et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl. J. Med. 367, 1187\u20131197 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1744_CR5","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1038\/sj.onc.1208053","volume":"23","author":"M Unoki","year":"2004","unstructured":"Unoki, M., Nishidate, T. & Nakamura, Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23, 7601\u20137610 (2004).","journal-title":"Oncogene"},{"key":"1744_CR6","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1147939","volume":"317","author":"M Bostick","year":"2007","unstructured":"Bostick, M. et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760\u20131764 (2007).","journal-title":"Science"},{"key":"1744_CR7","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1038\/onc.2011.641","volume":"31","author":"F Babbio","year":"2012","unstructured":"Babbio, F. et al. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene 31, 4878\u20134887 (2012).","journal-title":"Oncogene"},{"key":"1744_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-016-0308-0","volume":"35","author":"X Wan","year":"2016","unstructured":"Wan, X. et al. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy. J. Exp. Clin. Cancer Res. 35, 34 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1744_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/157489211793980024","volume":"6","author":"M Unoki","year":"2011","unstructured":"Unoki, M. Current and potential anticancer drugs targeting members of the UHRF1 complex including epigenetic modifiers. Recent Pat. Anticancer Drug Discov. 6, 116\u2013130 (2011).","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"1744_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-9966-30-41","volume":"30","author":"M Alhosin","year":"2011","unstructured":"Alhosin, M. et al. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J. Exp. Clin. Cancer Res. 30, 41 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1744_CR11","doi-asserted-by":"publisher","unstructured":"Ashraf, W. et al. Natural and synthetic anticancer epidrugs targeting the epigenetic integrator UHRF1. Molecules (Basel, Switzerland) 28, https:\/\/doi.org\/10.3390\/molecules28165997 (2023).","DOI":"10.3390\/molecules28165997"},{"key":"1744_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1021\/acs.biochem.1c00698","volume":"61","author":"WH Liu","year":"2022","unstructured":"Liu, W. H. et al. Discovery and mechanism of small molecule inhibitors selective for the chromatin-binding domains of oncogenic UHRF1. Biochemistry 61, 354\u2013366 (2022).","journal-title":"Biochemistry"},{"key":"1744_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41422-022-00735-6","volume":"32","author":"CL Hu","year":"2022","unstructured":"Hu, C. L. et al. Targeting UHRF1\u2013SAP30\u2013MXD4 axis for leukemia initiating cell eradication in myeloid leukemia. Cell Res. 32, 1105\u20131123 (2022).","journal-title":"Cell Res."},{"key":"1744_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ejmech.2016.02.043","volume":"114","author":"V Myrianthopoulos","year":"2016","unstructured":"Myrianthopoulos, V. et al. Tandem virtual screening targeting the SRA domain of UHRF1 identifies a novel chemical tool modulating DNA methylation. Eur. J. Med. Chem. 114, 390\u2013396 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"1744_CR15","doi-asserted-by":"publisher","unstructured":"Szumilak, M., Wiktorowska-Owczarek, A. & Stanczak, A. Hybrid drugs\u2014a strategy for overcoming anticancer drug resistance? Molecules (Basel, Switzerland) 26, https:\/\/doi.org\/10.3390\/molecules26092601 (2021).","DOI":"10.3390\/molecules26092601"},{"key":"1744_CR16","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.1021\/acs.jmedchem.1c00683","volume":"64","author":"X Li","year":"2021","unstructured":"Li, X., Li, X., Liu, F., Li, S. & Shi, D. Rational multitargeted drug design strategy from the perspective of a medicinal chemist. J. Med. Chem. 64, 10581\u201310605 (2021).","journal-title":"J. Med. Chem."},{"key":"1744_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0668-3","volume":"11","author":"T Niinuma","year":"2019","unstructured":"Niinuma, T. et al. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells. Clin. Epigenet. 11, 70 (2019).","journal-title":"Clin. Epigenet."},{"key":"1744_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-018-0810-7","volume":"37","author":"L Yin","year":"2018","unstructured":"Yin, L. et al. PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1\/BRCA1 DNA damage repair complex in prostate cancer cells. J. Exp. Clin. Cancer Res. 37, 153 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1744_CR19","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"1744_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature07273","volume":"455","author":"GV Avvakumov","year":"2008","unstructured":"Avvakumov, G. V. et al. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 455, 822\u2013825 (2008).","journal-title":"Nature"},{"key":"1744_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1080\/15384047.2015.1056411","volume":"16","author":"L Zhou","year":"2015","unstructured":"Zhou, L. et al. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation. Cancer Biol. Ther. 16, 1241\u20131251 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"1744_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104196","volume":"25","author":"D Aibara","year":"2022","unstructured":"Aibara, D. et al. Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation. iScience 25, 104196 (2022).","journal-title":"iScience"},{"key":"1744_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ni.2886","volume":"15","author":"Y Obata","year":"2014","unstructured":"Obata, Y. et al. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat. Immunol. 15, 571\u2013579 (2014).","journal-title":"Nat. Immunol."},{"key":"1744_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/cr.2011.124","volume":"21","author":"L Hu","year":"2011","unstructured":"Hu, L., Li, Z., Wang, P., Lin, Y. & Xu, Y. Crystal structure of PHD domain of UHRF1 and insights into recognition of unmodified histone H3 arginine residue 2. Cell Res. 21, 1374\u20131378 (2011).","journal-title":"Cell Res."},{"key":"1744_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113821","volume":"174","author":"C Bailly","year":"2020","unstructured":"Bailly, C. & Vergoten, G. Protein homodimer sequestration with small molecules: focus on PD-L1. Biochem. Pharm. 174, 113821 (2020).","journal-title":"Biochem. Pharm."},{"key":"1744_CR26","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1021\/acs.jmedchem.7b00293","volume":"60","author":"K Guzik","year":"2017","unstructured":"Guzik, K. et al. Small-molecule inhibitors of the programmed cell death-1\/programmed death\u2013ligand 1 (PD-1\/PD-L1) interaction via transiently induced protein states and dimerization of PD-L1. J. Med. Chem. 60, 5857\u20135867 (2017).","journal-title":"J. Med. Chem."},{"key":"1744_CR27","doi-asserted-by":"publisher","unstructured":"Carabet, L. A., Rennie, P. S. & Cherkasov, A. Therapeutic inhibition of Myc in cancer. Structural bases and computer-aided drug discovery approaches. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20010120 (2018).","DOI":"10.3390\/ijms20010120"},{"key":"1744_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bmcl.2008.12.025","volume":"19","author":"AV Follis","year":"2009","unstructured":"Follis, A. V., Hammoudeh, D. I., Daab, A. T. & Metallo, S. J. Small-molecule perturbation of competing interactions between c-Myc and Max. Bioorg. Med. Chem. Lett. 19, 807\u2013810 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1744_CR29","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1093\/nar\/gkz077","volume":"47","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Structural basis for DNA recognition by FOXC2. Nucleic Acids Res. 47, 3752\u20133764 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1744_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s41365-019-0683-2","volume":"30","author":"W-Z Zhang","year":"2019","unstructured":"Zhang, W.-Z. et al. The protein complex crystallography beamline (BL19U1) at the Shanghai Synchrotron Radiation Facility. Nucl. Sci. Tech. 30, 170 (2019).","journal-title":"Nucl. Sci. Tech."},{"key":"1744_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"1744_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymeth.2011.07.005","volume":"55","author":"PD Adams","year":"2011","unstructured":"Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods (San Diego, CA) 55, 94\u2013106 (2011).","journal-title":"Methods (San Diego, CA)"},{"key":"1744_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"1744_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski, R. A., Jab\u0142o\u0144ska, J., Pravda, L., Va\u0159ekov\u00e1, R. S. & Thornton, J. M. PDBsum: structural summaries of PDB entries. Protein Sci. 27, 129\u2013134 (2018).","journal-title":"Protein Sci."},{"key":"1744_CR35","doi-asserted-by":"crossref","unstructured":"Bramucci, E., Paiardini, A., Bossa, F. & Pascarella, S. PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL. BMC Bioinform. 13, S2 (2012).","DOI":"10.1186\/1471-2105-13-S4-S2"},{"key":"1744_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2144\/000112036","volume":"40","author":"YJ Shyu","year":"2006","unstructured":"Shyu, Y. J., Liu, H., Deng, X. & Hu, C.-D. Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques 40, 61\u201366 (2006).","journal-title":"Biotechniques"}],"container-title":["Communications Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01744-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T01:04:23Z","timestamp":1763514263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42004-025-01744-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1038\/s42004-025-01744-3","relation":{},"ISSN":["2399-3669"],"issn-type":[{"value":"2399-3669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}